Max Verstappen's success in his debut CUP3 race has led to Germany's federation re-evaluating its criteria for a DMSB permit.

This week's letters to the editor, featuring your views on local and national politics as well as their effects on our ...

Oral presentation of Lynozyfic™ (linvoseltamab-gcpt) data in newly diagnosed multiple myeloma from LINKER-MM4, the first trial to evaluate a BCMAxCD3 bispecific antibody as a monotherapy in this ...